Oxytocin receptors expressed and coupled to Ca2+ signalling in a human vascular smooth muscle cell line

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 799-804

  Yazawa, Hidenori ^a   Hirasawa, Akira ^b   Horie, Kuniko ^b   Saita, Yuji ^a   Iida, Emi ^a   Honda, Kazuo ^a   Tsujimoto, Gozoh ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Human vascular smooth muscle cell line; Intracellular ca2+; inositol (1,4,5) trisphosphate; Oxytocin receptor; Reverse transcription polymerase chain reaction

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; ARGIPRESSIN; CALCIUM ION; DESMOPRESSIN; INOSITOL 1,4,5 TRISPHOSPHATE; MOZAVAPTAN; OXYTOCIN; OXYTOCIN RECEPTOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM CELL LEVEL; HUMAN; HUMAN CELL; MUSCLE FIBER CULTURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARGININE VASOPRESSIN; CALCIUM; CELL LINE; FLUORESCENT DYES; FURA-2; HUMANS; INOSITOL PHOSPHATES; MUSCLE, SMOOTH, VASCULAR; OXYTOCIN; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0029865852     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15263.x     Document Type: Article

References (26)

1. ALTURA, B.M. & ALTURA, B.T. (1984). Actions of vasopressin, oxytocin, and synthetic analogs on vascular smooth muscle. Fed. Proc., 43, 80-86.
2. BIRNBAUMER, M., SHIBOLD, A., GILBERT, S., ISHIDO, M., BARBERIS, C., ANTARAMIAN, A., BRABET, P. & ROSENTHAL, W. (1992). Molecular cloning of the receptor for human antiduretic hormone. Nature, 357, 333-335.
3. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem., 72, 248-254.
4. BRINER, V.A., TSAI, P., CHOONG, H.L. & SCHRIER, R.W. (1992). Comparative effects of arginine vasopressin and oxytocin in cell culture systems. Am. J. Physiol., 263, F222-F227.
5. CHAN, W.Y., CHEN, D.L. & MANNING, M. (1993). Oxytocin receptor subtypes in the pregnant rat myometrium and decidua: pharmacological differentiations. Endocrinology, 132, 1381-1386.
6. DELEAN, A., MUNSON, P.J., & ROBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E102.
7. GAVRAS, H. (1990). Pressor systems in hypertension and congestive heart failure: Role of vasopressin. Hypertension, 16, 587-593.
8. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
9. 2 receptor mRNA in rats. Eur. J. Pharmacol. Mol. Pharmacol., 267, 71-75.
10. HIRASAWA, A., SHIBATA, K., KOTOSAI, K. & TSUJIMOTO, G. (1994b). Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor. Biochem. Bniphys. Res. Commun., 203, 71-79.
11. 1C-adrenergic receptor mRNA in bovine retinal pigment epithelium. Invest. Ophthalmol. Visual. Sci., 34, 2769-2775.
12. KIMURA, T., TANIZAWA, O., MORI K., BROWNSTEIN, M.J. & OKAYAMA, H. (1992). Structure and expression of a human oxytocin receptor. Nature, 356, 526-529.
13. LASLZO, F.A., LASZLO, Jr. F. & WIED, D.D. (1991). Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol. Rev., 43, 73-108.
14. LOLAIT, S.J., O'CARROLL, A.M. MCBRIDE, O.W., KONIG, M., MOREL, M. & BROWNSTEIN, M.J. (1992). Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature, 357, 336-339.
15. MANNING, M. & SAWYER, W.H. (1991). Antagonists of vasopressin and oxytocin: Current status and future perspectives. In Vasopressin. ed. Jard, S. & Jamison, R. pp. 297-309. Paris: John Libbey Eurotext, Ltd.
16. MOREL, A., O'CARROLL, A.M., BROWNSTEIN, M.J. & LOLAIT, S.J. (1992). Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature, 356, 523-526.
17. NAKANO J. (1973). Cardiovascular actions of oxytocin. Obstet. Gynecol. Surv., 28, 75-92.
18. PEDERSEN, C.A. & PRANGE, Jr, A.J. (1979). Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proc. Natl. Acad. Sci. U.S.A., 76, 6661-6665.
19. PETTIBONE, D.J., KISHEL, M.T., WOYDEN, C.J., CLINESCHMIDT, B.V., BOCK, M.G., FREIDINGER, R.M., VEBER, D.F. & WILLIAMS, P.D. (1992). Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues. Life Sci., 50, 1953-1958.
20. 3H]-phosphatidylbutanol accumulation in A10 vascular smooth muscle cells. Br. J. Pharmacol., 107, 109-115.
21. RICHARD, P.M., MOOS, F & FREUD-MERCIER, M.J. (1991). Central effects of oxytocin. Physiol. Rev., 71, 331-370.
22. SCALA-GUENOT, D.D.I. & STROSSER, M.T. (1992). Oxytocin receptors on cultured astroglial cells. Biochem. J., 284, 491-497.
23. SHARE, L. (1988). Role of vasopressin in cardiovascular regulation. Physiol. Rev., 68, 1248-1284.
24. THIBONNIER, M., AUZAN, C., MADHUM, Z., WILKINS, P., BERTIMATTERA, L. & CLAVSER, E. (1994). Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J. Biol. Chem., 269, 3304-3310.
25. THIBONNIER, M., BAYER, A.L., SIMONSON, M.S. & KESTER, M. (1991). Multiple signaling pathways of V1-vascular vasopressin receptors of A7r5 cells. Endocrinology, 129, 2845-2856.
26. 3H](0-ethoxyphenoxy)ethyl]amino]-propyl]-2-methoxybenzenesufonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand. J. Pharmacol. Exp. Ther., 263, 201-206.